BioNeutra Global Corporation (TSXV:BGA)
Canada · Delayed Price · Currency is CAD 0.0300
-0.0150 (-33.33%)
At close: May 6, 2025
BioNeutra Global Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 10.86 | 11.38 | 13.39 | 15.4 | 24.12 | 37.7 | |
Revenue Growth (YoY) | -3.62% | -15.00% | -13.05% | -36.14% | -36.03% | -0.04% |
Cost of Revenue | 6.21 | 7.24 | 11.04 | 12.51 | 20.17 | 37.06 |
Gross Profit | 4.65 | 4.14 | 2.35 | 2.89 | 3.94 | 0.64 |
Selling, General & Admin | 5.14 | 4.83 | 4.63 | 5.32 | 6.56 | 8.14 |
Research & Development | 0.1 | 0.15 | -0.02 | 0.01 | 0.26 | 0.44 |
Amortization of Goodwill & Intangibles | 0.09 | 0.09 | 0.07 | 0.23 | 0.51 | 0.75 |
Operating Expenses | 5.46 | 5.24 | 4.82 | 6.13 | 7.55 | 9.42 |
Operating Income | -0.81 | -1.1 | -2.47 | -3.24 | -3.6 | -8.78 |
Interest Expense | -0.79 | -0.7 | -0.45 | -0.39 | -0.43 | -0.6 |
Interest & Investment Income | 0.28 | 0.12 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.01 | -0.09 | 0.04 | -0.09 | -0.09 | -1.06 |
EBT Excluding Unusual Items | -1.32 | -1.77 | -2.88 | -3.71 | -4.12 | -10.43 |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | -0.04 | - | -0.1 | - |
Legal Settlements | - | - | - | - | - | -0.64 |
Other Unusual Items | 0.67 | -0.38 | - | 0.88 | 0.44 | -1.94 |
Pretax Income | -0.61 | -2.11 | -2.92 | -2.83 | -3.77 | -13.02 |
Income Tax Expense | - | - | - | - | -0.06 | -0.58 |
Net Income | -0.61 | -2.11 | -2.92 | -2.83 | -3.71 | -12.44 |
Net Income to Common | -0.61 | -2.11 | -2.92 | -2.83 | -3.71 | -12.44 |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Change (YoY) | - | - | - | - | - | 0.19% |
EPS (Basic) | -0.01 | -0.05 | -0.06 | -0.06 | -0.08 | -0.27 |
EPS (Diluted) | -0.02 | -0.05 | -0.06 | -0.06 | -0.08 | -0.27 |
Free Cash Flow | -0.57 | 0.66 | 0.72 | -0.39 | 1.4 | 0.56 |
Free Cash Flow Per Share | -0.01 | 0.01 | 0.01 | -0.01 | 0.03 | 0.01 |
Gross Margin | 42.84% | 36.40% | 17.54% | 18.77% | 16.36% | 1.69% |
Operating Margin | -7.43% | -9.66% | -18.42% | -21.03% | -14.94% | -23.30% |
Profit Margin | -5.62% | -18.52% | -21.82% | -18.37% | -15.37% | -33.01% |
Free Cash Flow Margin | -5.28% | 5.83% | 5.37% | -2.53% | 5.82% | 1.50% |
EBITDA | -0.35 | -0.04 | -1.41 | -1.97 | -1.82 | -6.51 |
EBITDA Margin | -3.22% | -0.37% | -10.53% | -12.79% | -7.53% | -17.27% |
D&A For EBITDA | 0.46 | 1.06 | 1.06 | 1.27 | 1.79 | 2.27 |
EBIT | -0.81 | -1.1 | -2.47 | -3.24 | -3.6 | -8.78 |
EBIT Margin | -7.43% | -9.66% | -18.42% | -21.03% | -14.94% | -23.30% |